Cargando…

Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran

BACKGROUND AND PURPOSE: Otomycosis is a secondary ear fungal infection among predisposed individuals in humid conditions. Aspergillus species are the most common etiologic agents of this infection. Several ototopical antifungals are currently used for the treatment of this disease; however, recurren...

Descripción completa

Detalles Bibliográficos
Autores principales: Gharaghani, Maral, Halvaeezadeh, Marzieh, Ali Jalaee, Gholam, Taghipour, Simin, Kiasat, Neda, Zarei Mahmoudabadi, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Society of Medical Mycology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888522/
https://www.ncbi.nlm.nih.gov/pubmed/33628977
http://dx.doi.org/10.18502/CMM.6.2.2696
_version_ 1783652181521465344
author Gharaghani, Maral
Halvaeezadeh, Marzieh
Ali Jalaee, Gholam
Taghipour, Simin
Kiasat, Neda
Zarei Mahmoudabadi, Ali
author_facet Gharaghani, Maral
Halvaeezadeh, Marzieh
Ali Jalaee, Gholam
Taghipour, Simin
Kiasat, Neda
Zarei Mahmoudabadi, Ali
author_sort Gharaghani, Maral
collection PubMed
description BACKGROUND AND PURPOSE: Otomycosis is a secondary ear fungal infection among predisposed individuals in humid conditions. Aspergillus species are the most common etiologic agents of this infection. Several ototopical antifungals are currently used for the treatment of this disease; however, recurrence and treatment failure are usually observed in some cases. Regarding this, the present study was conducted to investigate the antifungal activity of caspofungin, azoles, and terbinafine against the isolated agents of otomycosis. MATERIALS AND METHODS: This study was conducted on the specimens collected from 90 patients with otomycosis. The samples were cultured on Sabouraud dextrose agar and identified based on morphological characteristics, physiological tests, and microscopic features. Furthermore, the microdilution method was used for antifungal susceptibility testing according to the Clinical and Laboratory Standards Institute (CLSI) guidelines. Finally, the minimum inhibitory concentration (MIC) and minimum effective concentration (MEC) ranges, MIC/MEC(50), MIC/MEC(90), and geometric mean (GM) MIC/MEC were calculated for the isolates. RESULTS: According to the results, 77 patients with otomycosis were positive for different Aspergillus (88.3%) and Candida (11.7%) species. Aspergillus niger complex (n=36) was found to be the most common agent, followed by A. flavus, A. terreus, and A. nidulans complexes. Furthermore, epidemiological cutoff values (ECVs) were lower than those presented by the CLSI for itraconazole and caspofungin in 98.5% and 42.6% of Aspergillus species, respectively. Terbinafine exhibited a great activity against Aspergillus species, while fluconazole revealed a low activity against both Aspergillus species. Based on the results, 77.8% of Candida species were resistant to caspofungin; however, miconazole and econazole had low MIC ranges. CONCLUSION: Aspergillus niger and A. flavus complexes were identified as the most common agents accounting for 85.7% of the isolates. In addition, terbinafine was identified as the best antifungal for both Aspergillus and Candida species. Moreover, tested azoles had relatively low MICs, whereas most of the isolates had the MIC values beyond the caspofungin ECVs.
format Online
Article
Text
id pubmed-7888522
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Iranian Society of Medical Mycology
record_format MEDLINE/PubMed
spelling pubmed-78885222021-02-23 Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran Gharaghani, Maral Halvaeezadeh, Marzieh Ali Jalaee, Gholam Taghipour, Simin Kiasat, Neda Zarei Mahmoudabadi, Ali Curr Med Mycol Original Article BACKGROUND AND PURPOSE: Otomycosis is a secondary ear fungal infection among predisposed individuals in humid conditions. Aspergillus species are the most common etiologic agents of this infection. Several ototopical antifungals are currently used for the treatment of this disease; however, recurrence and treatment failure are usually observed in some cases. Regarding this, the present study was conducted to investigate the antifungal activity of caspofungin, azoles, and terbinafine against the isolated agents of otomycosis. MATERIALS AND METHODS: This study was conducted on the specimens collected from 90 patients with otomycosis. The samples were cultured on Sabouraud dextrose agar and identified based on morphological characteristics, physiological tests, and microscopic features. Furthermore, the microdilution method was used for antifungal susceptibility testing according to the Clinical and Laboratory Standards Institute (CLSI) guidelines. Finally, the minimum inhibitory concentration (MIC) and minimum effective concentration (MEC) ranges, MIC/MEC(50), MIC/MEC(90), and geometric mean (GM) MIC/MEC were calculated for the isolates. RESULTS: According to the results, 77 patients with otomycosis were positive for different Aspergillus (88.3%) and Candida (11.7%) species. Aspergillus niger complex (n=36) was found to be the most common agent, followed by A. flavus, A. terreus, and A. nidulans complexes. Furthermore, epidemiological cutoff values (ECVs) were lower than those presented by the CLSI for itraconazole and caspofungin in 98.5% and 42.6% of Aspergillus species, respectively. Terbinafine exhibited a great activity against Aspergillus species, while fluconazole revealed a low activity against both Aspergillus species. Based on the results, 77.8% of Candida species were resistant to caspofungin; however, miconazole and econazole had low MIC ranges. CONCLUSION: Aspergillus niger and A. flavus complexes were identified as the most common agents accounting for 85.7% of the isolates. In addition, terbinafine was identified as the best antifungal for both Aspergillus and Candida species. Moreover, tested azoles had relatively low MICs, whereas most of the isolates had the MIC values beyond the caspofungin ECVs. Iranian Society of Medical Mycology 2020-06 /pmc/articles/PMC7888522/ /pubmed/33628977 http://dx.doi.org/10.18502/CMM.6.2.2696 Text en Copyright: © 2020, Published by Mazandaran University of Medical Sciences on behalf of Iranian Society of Medical Mycology and Invasive Fungi Research Center. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Unported License, ( http://creativecommons.org/licenses/by/4.0/ ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Gharaghani, Maral
Halvaeezadeh, Marzieh
Ali Jalaee, Gholam
Taghipour, Simin
Kiasat, Neda
Zarei Mahmoudabadi, Ali
Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran
title Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran
title_full Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran
title_fullStr Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran
title_full_unstemmed Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran
title_short Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran
title_sort antifungal susceptibility profiles of otomycosis etiological agents in ahvaz, iran
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888522/
https://www.ncbi.nlm.nih.gov/pubmed/33628977
http://dx.doi.org/10.18502/CMM.6.2.2696
work_keys_str_mv AT gharaghanimaral antifungalsusceptibilityprofilesofotomycosisetiologicalagentsinahvaziran
AT halvaeezadehmarzieh antifungalsusceptibilityprofilesofotomycosisetiologicalagentsinahvaziran
AT alijalaeegholam antifungalsusceptibilityprofilesofotomycosisetiologicalagentsinahvaziran
AT taghipoursimin antifungalsusceptibilityprofilesofotomycosisetiologicalagentsinahvaziran
AT kiasatneda antifungalsusceptibilityprofilesofotomycosisetiologicalagentsinahvaziran
AT zareimahmoudabadiali antifungalsusceptibilityprofilesofotomycosisetiologicalagentsinahvaziran